| This article has been cited by |
| 1 | Acute Kidney Injury and Renal Recovery with the Use of Aminoglycosides: A Large Retrospective Study | |
| François Paquette,Amélie Bernier-Jean,Véronique Brunette,Hélène Ammann,Valéry Lavergne,Vincent Pichette,Stéphan Troyanov,Josée Bouchard |
| Nephron.2015;131(3)153 |
| [DOI] |
|
| 2 | Acute Kidney Injury and Renal Recovery with the Use of Aminoglycosides: A Large Retrospective Study | |
| K. N. Woodward |
| Nephron.2012;131(3)273 |
| [DOI] |
|
| 3 | Acute Kidney Injury and Renal Recovery with the Use of Aminoglycosides: A Large Retrospective Study | |
| Vikas Yellapu,Daniel Ackerman,Santo Longo,Stanislaw P. Stawicki |
| Nephron.2018;131(3)273 |
| [DOI] |
|
| 4 | Piperacillin/Tazobactam versus Tobramycin-Based Antibiotic Prophylaxis for Type III Open Fractures | |
| Suhair K. Shawar,Thuan V. Ly,Junan Li,Mary Beth Shirk,Erin M. Reichert |
| Surgical Infections.2020;21(1)23 |
| [DOI] |
|
| 5 | Piperacillin/Tazobactam versus Tobramycin-Based Antibiotic Prophylaxis for Type III Open Fractures | |
| Adrian Wong,Sandra L. Kane-Gill |
| Surgical Infections.2019;21(1)539 |
| [DOI] |
|
| 6 | Épidémiologie de l’insuffisance rénale aiguë | |
| Julien Aniort,Anne-Élisabeth Heng,Patrice Deteix,Bertrand Souweine,Alexandre Lautrette |
| Néphrologie & Thérapeutique.2019;15(1)63 |
| [DOI] |
|
| 7 | Bronchiectasis and inhaled tobramycin: A literature review | |
| J. Stuart Elborn,Francesco Blasi,Charles S. Haworth,Manfred Ballmann,Harm A.W.M. Tiddens,Marlène Murris-Espin,James D. Chalmers,André M. Cantin |
| Respiratory Medicine.2022;192(1)106728 |
| [DOI] |
|
| 8 | Evaluation of the clinical practice of aminoglycoside use in paediatric patients in Kenya: findings and implications for lower-middle income countries | |
| Elias Joseph Onyango,Faith Okalebo,Margaret Oluka,Rosaline Kinuthia,Loice Achieng,Brian Godman,Amanj Kurdi |
| JAC-Antimicrobial Resistance.2020;2(1)106728 |
| [DOI] |
|
| 9 | Therapeutic drug monitoring of amikacin in septic patients | |
| Wieslawa Duszynska,Fabio Taccone,Magdalena Hurkacz,Beata Kowalska-Krochmal,Anna Wiela-Hojenska,Andrzej Kübler |
| Critical Care.2013;17(4)R165 |
| [DOI] |
|
| 10 | Antimicrobial therapy with aminoglycoside or meropenem in the intensive care unit for hospital associated infections and risk factors for acute kidney injury | |
| Raphael Donadio Pitta,Juliano Gasparetto,Thyago Proença De Moraes,João Paulo Telles,Felipe Francisco Tuon |
| European Journal of Clinical Microbiology & Infectious Diseases.2020;39(4)723 |
| [DOI] |
|
| 11 | Risk factors for acute kidney injury during aminoglycoside therapy in patients with cystic fibrosis | |
| Kevin J. Downes,Neha R. Patil,Marepalli B. Rao,Rajesh Koralkar,William T. Harris,John P. Clancy,Stuart L. Goldstein,David J. Askenazi |
| Pediatric Nephrology.2015;30(10)1879 |
| [DOI] |
|
| 12 | The 6R’s of drug induced nephrotoxicity | |
| Linda Awdishu,Ravindra L. Mehta |
| BMC Nephrology.2017;18(1)1879 |
| [DOI] |
|
| 13 | Detection of subclinical nephrotoxicity induced by aminoglycosides in critically ill elderly patients using trough levels and urinary neutrophil gelatinase-associated lipocalin | |
| Kourosh Sadeghi,Bita Shahrami,Faezeh Hosseini Fani,Hadi Hamishehkar,Mojtaba Mojtahedzadeh |
| European Journal of Hospital Pharmacy.2022;29(e1)e63 |
| [DOI] |
|
